The aim of this work is to evaluate the effects of fractionated radiation exposure on the expression level of vimentin, which is one of the EMT end-stage markers in cervical cancers in vitro and in vivo, including the association of postradiation changes in vimentin expression with CSC radiation response and short-term prognosis. This evidence concerns the gene VIM and cervical carcinoma.